- Home
- MIAX vs LNTH Comparison
MIAX vs LNTH Comparison
Compare MIAX & LNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MIAX | LNTH |
|---|---|---|
| Founded | 2007 | 1956 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Bankers/Brokers/Service | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.8B | 4.4B |
| IPO Year | 2025 | 2015 |
Fundamental Metrics
Financial Performance| Metric | MIAX | LNTH |
|---|---|---|
| Price | $44.42 | $67.31 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 6 | 6 |
| Target Price | $47.20 | ★ $78.00 |
| AVG Volume (30 Days) | ★ 963.0K | 835.0K |
| Earning Date | 02-22-2026 | 02-25-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 2.39 |
| Revenue | $1,318,535,000.00 | ★ $1,525,933,000.00 |
| Revenue This Year | N/A | $0.01 |
| Revenue Next Year | $19.58 | $0.26 |
| P/E Ratio | ★ N/A | $27.77 |
| Revenue Growth | ★ 22.86 | 1.95 |
| 52 Week Low | $28.63 | $47.25 |
| 52 Week High | $51.38 | $111.29 |
Technical Indicators
Market Signals| Indicator | MIAX | LNTH |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 58.15 |
| Support Level | N/A | $63.37 |
| Resistance Level | N/A | $70.33 |
| Average True Range (ATR) | 0.00 | 2.06 |
| MACD | 0.00 | -0.44 |
| Stochastic Oscillator | 0.00 | 57.61 |
Price Performance
Historical ComparisonAbout MIAX Miami International Holdings Inc.
Miami International Holdings Inc is a technology-driven leader in building and operating regulated financial marketplaces across multiple asset classes and geographies. Its MIAX Exchange marketplaces are enabled by its in-house built, proprietary technology. It maintains a broad portfolio of U.S. exchange and clearing licenses, in both securities and futures. The company operates markets across a diverse number of asset classes including options and cash equities as well as futures and options on futures.
About LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.